Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1996-8-23
pubmed:abstractText
We analysed the induction of tolerance to nitrates both in the vasculature (in vivo) and platelets (ex vivo). Simultaneously, we tested mechanisms underlying the induction of tolerance and interventions to prevent or overcome this phenomenon. For this purpose nitroglycerin (GTN 1.5 micrograms/kg per min i.v.), alone or in combination with ascorbate (55 micrograms/kg per min i.v.) as antioxidant, was infused continuously for a period of 5 days into chronically instrumented dogs. Along with haemodynamic parameters, ex vivo platelet function was continuously monitored. Following the start of GTN infusions there was a maximal coronary dilator response (245 +/- 15 microm) and, as an index of venodilation, a fall of left ventricular end-diastolic pressure (by 2.3 +/- 0.4 mmHg). Both responses declined progressively and disappeared during the infusion period. However, in combination with ascorbate as antioxidant the dilator responses were maintained fully throughout the infusion period. With GTN alone there was a progressive, unexpected upregulation of platelet activity demonstrated by enhanced thrombin-stimulated intracellular Ca2+ levels and increases in the microviscosity of platelet membranes (indicating enhanced receptor expression) associated with a progressive impairment in basal, unstimulated cGMP levels. These changes could also be prevented completely by i.v. co-administration of ascorbate. From these results it is concluded that vascular tolerance is closely reflected by simultaneous changes in platelet function and further, that both can be prevented completely by appropriate antioxidants such as ascorbate.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
353
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
363-7
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:8692294-Animals, pubmed-meshheading:8692294-Antioxidants, pubmed-meshheading:8692294-Ascorbic Acid, pubmed-meshheading:8692294-Blood Platelets, pubmed-meshheading:8692294-Blood Pressure, pubmed-meshheading:8692294-Calcium, pubmed-meshheading:8692294-Cyclic GMP, pubmed-meshheading:8692294-Dogs, pubmed-meshheading:8692294-Drug Interactions, pubmed-meshheading:8692294-Drug Synergism, pubmed-meshheading:8692294-Drug Tolerance, pubmed-meshheading:8692294-Female, pubmed-meshheading:8692294-Infusions, Intravenous, pubmed-meshheading:8692294-Male, pubmed-meshheading:8692294-Muscle, Smooth, Vascular, pubmed-meshheading:8692294-Nitroglycerin, pubmed-meshheading:8692294-Thrombin, pubmed-meshheading:8692294-Up-Regulation, pubmed-meshheading:8692294-Vasodilator Agents, pubmed-meshheading:8692294-Ventricular Function, Left
pubmed:year
1996
pubmed:articleTitle
Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state.
pubmed:affiliation
Institut für Angewandte Physiologie, Universität Freiburg, Germany.
pubmed:publicationType
Journal Article